Login

Shawn Shirazi, Chief Executive Officer , Theralase Technologies Inc. 00:00:00

Share On Facebook Share On Twitter

Shawn Shirazi, Chief Executive Officer , Theralase Technologies Inc.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Houlihan Lokey CEO Scott Beiser celebrates the firm's IPO at the NYSE, discussing M&A activity and key trends in restructuring.
00:10:00
Understanding Market Dynamics: Lessons from a Seasoned Investor | Jeremy Grantham, co-founder , GMO LLC.
00:10:00
Epiroc and Fordia Launch 'One Face of Exploration' to Streamline Service and Products
00:10:00
Abijit Bora's Analysis of the Union Budget Highlights Fiscal Prudence and Sector Impacts
00:10:00
Marco Claudio Grillo Discusses Abitare In’s Milestones and Future Goals at AIM Investor Day | Marco Claudio Grillo, CEO , Abitare In SpA.
00:00:00
CEL-SCI Corp letter to shareholders details positive results from Phase 3 study of Multikine - Geert R. Kersten Director and Chief Executive Officer, CEL-SCI Corp
00:00:00
Petter Bäckgren, CEO, Bioservo Technologies
00:10:00
Tim Brown's Journey from Merino Wool to Revolutionary Footwear with Allbirds | Tim Brown, Co-Founder, Allbirds Inc.
00:10:00
Nily Levy: Veteran Wealth Manager and Asset Protection Expert | Nily Levy - Wealth Advisor - California, Paragon Capital Management, Ltd.
00:10:00
investments in enterprise cloud and smart data companies|Clint Korver, Managing Director,Ulu Ventures
00:10:00
Michael Saylor, Chairman & CEO of MicroStrategy, Inc., speaks with Bloomberg's Joe Weisenthal at the Bloomberg Crypto Summit about cryptocurrency strategies.
00:10:00
Disclosure: Securities and Advisory Services through M Holdings Securities and Eslick Financial Group

© 2017 - Neuhu+